These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 24704820

  • 1. Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells.
    Chung S, Lin YL, Reed C, Ng C, Cheng ZJ, Malavasi F, Yang J, Quarmby V, Song A.
    J Immunol Methods; 2014 May; 407():63-75. PubMed ID: 24704820
    [Abstract] [Full Text] [Related]

  • 2. An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.
    Sung AP, Tang JJ, Guglielmo MJ, Redelman D, Smith-Gagen J, Bateman L, Hudig D.
    J Immunol Methods; 2018 Jan; 452():63-72. PubMed ID: 29113954
    [Abstract] [Full Text] [Related]

  • 3. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies.
    Cheng ZJ, Garvin D, Paguio A, Moravec R, Engel L, Fan F, Surowy T.
    J Immunol Methods; 2014 Dec 01; 414():69-81. PubMed ID: 25086226
    [Abstract] [Full Text] [Related]

  • 4. Characterization of FcγRIIIA effector cells used in in vitro ADCC bioassay: Comparison of primary NK cells with engineered NK-92 and Jurkat T cells.
    Hsieh YT, Aggarwal P, Cirelli D, Gu L, Surowy T, Mozier NM.
    J Immunol Methods; 2017 Feb 01; 441():56-66. PubMed ID: 27939300
    [Abstract] [Full Text] [Related]

  • 5. Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.
    Repp R, Kellner C, Muskulus A, Staudinger M, Nodehi SM, Glorius P, Akramiene D, Dechant M, Fey GH, van Berkel PH, van de Winkel JG, Parren PW, Valerius T, Gramatzki M, Peipp M.
    J Immunol Methods; 2011 Oct 28; 373(1-2):67-78. PubMed ID: 21855548
    [Abstract] [Full Text] [Related]

  • 6. Impaired antibody-dependent cellular cytotoxicity mediated by herceptin in patients with gastric cancer.
    Kono K, Takahashi A, Ichihara F, Sugai H, Fujii H, Matsumoto Y.
    Cancer Res; 2002 Oct 15; 62(20):5813-7. PubMed ID: 12384543
    [Abstract] [Full Text] [Related]

  • 7. Development of an ELISA based bridging assay as a surrogate measure of ADCC.
    Miller AS, Tejada ML, Gazzano-Santoro H.
    J Immunol Methods; 2012 Nov 30; 385(1-2):45-50. PubMed ID: 22914441
    [Abstract] [Full Text] [Related]

  • 8. Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies.
    Schnueriger A, Grau R, Sondermann P, Schreitmueller T, Marti S, Zocher M.
    Mol Immunol; 2011 Jul 30; 48(12-13):1512-7. PubMed ID: 21570725
    [Abstract] [Full Text] [Related]

  • 9. IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab.
    Patel D, Guo X, Ng S, Melchior M, Balderes P, Burtrum D, Persaud K, Luna X, Ludwig DL, Kang X.
    Hum Antibodies; 2010 Jul 30; 19(4):89-99. PubMed ID: 21178280
    [Abstract] [Full Text] [Related]

  • 10. Thaw-and-use target cells pre-labeled with calcein AM for antibody-dependent cell-mediated cytotoxicity assays.
    Chung S, Nguyen V, Lin YL, Kamen L, Song A.
    J Immunol Methods; 2017 Aug 30; 447():37-46. PubMed ID: 28434980
    [Abstract] [Full Text] [Related]

  • 11. Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871.
    Liu Z, Lee FT, Hanai N, Smyth FE, Burgess AW, Old LJ, Scott AM.
    Cancer Immun; 2002 Oct 07; 2():13. PubMed ID: 12747758
    [Abstract] [Full Text] [Related]

  • 12. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR, Woodhouse C, Morgan AC, Herberman RB, Cheresh DA, Reisfeld R.
    J Immunol; 1987 May 15; 138(10):3566-72. PubMed ID: 2437198
    [Abstract] [Full Text] [Related]

  • 13. High concentrations of therapeutic IgG1 antibodies are needed to compensate for inhibition of antibody-dependent cellular cytotoxicity by excess endogenous immunoglobulin G.
    Preithner S, Elm S, Lippold S, Locher M, Wolf A, da Silva AJ, Baeuerle PA, Prang NS.
    Mol Immunol; 2006 Mar 15; 43(8):1183-93. PubMed ID: 16102830
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.
    Niwa R, Hatanaka S, Shoji-Hosaka E, Sakurada M, Kobayashi Y, Uehara A, Yokoi H, Nakamura K, Shitara K.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6248-55. PubMed ID: 15448014
    [Abstract] [Full Text] [Related]

  • 15. Expression of human FcgammaRIIIa as a GPI-linked molecule on CHO cells to enable measurement of human IgG binding.
    Armour KL, Smith CS, Clark MR.
    J Immunol Methods; 2010 Mar 31; 354(1-2):20-33. PubMed ID: 20138184
    [Abstract] [Full Text] [Related]

  • 16. Inhibiting N-glycan processing increases the antibody binding affinity and effector function of human natural killer cells.
    Rodriguez Benavente MC, Hughes HB, Kremer PG, Subedi GP, Barb AW.
    Immunology; 2023 Oct 31; 170(2):202-213. PubMed ID: 37218360
    [Abstract] [Full Text] [Related]

  • 17. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays.
    Mata MM, Mahmood F, Sowell RT, Baum LL.
    J Immunol Methods; 2014 Apr 31; 406():1-9. PubMed ID: 24561308
    [Abstract] [Full Text] [Related]

  • 18. Correlation of ADCC activity with cytokine release induced by the stably expressed, glyco-engineered humanized Lewis Y-specific monoclonal antibody MB314.
    Kircheis R, Halanek N, Koller I, Jost W, Schuster M, Gorr G, Hajszan K, Nechansky A.
    MAbs; 2012 Apr 31; 4(4):532-41. PubMed ID: 22665069
    [Abstract] [Full Text] [Related]

  • 19. Effects of Soluble Tumor Necrosis Factor (TNF) on Antibody-Dependent Cellular Cytotoxicity of Therapeutic anti-TNF-α Antibody.
    Hirosaki H, Maeda Y, Shimojima M, Maeda K, Iwata H, Takeyoshi M.
    Immunol Invest; 2019 Jul 31; 48(5):441-450. PubMed ID: 30569777
    [Abstract] [Full Text] [Related]

  • 20. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15.
    Loubeau M, Ahmad A, Toma E, Menezes J.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Nov 01; 16(3):137-45. PubMed ID: 9390564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.